| abstract |
Compounds of formula (I) or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and in therapy, for example cancer, in particular mTOR kinase and / or one or more thereof Their use in the treatment of proliferative diseases such as diseases mediated by more PI3K enzymes. |